ARROWHEAD PHARMACEUTICALS, INC. ARWR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-12-14
ARROWHEAD PHARMACEUTICALS, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 15,683,206 | $407.6M |
| D. E. Shaw & Co., Inc. | 1,192,838 | $74.8M |
| RENAISSANCE TECHNOLOGIES LLC | 1,036,495 | $65.0M |
| CITADEL ADVISORS LLC | 350,494 | $22.0M |
| AQR CAPITAL MANAGEMENT LLC | 167,210 | $10.3M |
| Bridgewater Associates, LP | 95,552 | $6.0M |
| Point72 Asset Management, L.P. | 46,400 | $2.9M |
| TWO SIGMA INVESTMENTS, LP | 45,700 | $2.9M |
Source: SEC EDGAR filings · CIK 0000879407 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.